HOFSETH BIOCARE ASA: årsregnskap 2015 vs 2014
Grew 184% on revenue, weaker earnings
approved 2016-04-22; registry 2016-07-12; journal 2016 674922
Summary
What changed
Comparing Årsregnskap 2015 with 2014 for HOFSETH BIOCARE ASA. Revenue 19.29m NOK → 54.78m NOK (+184.0%). Net result -66.92m NOK → -100.20m NOK. Equity 92.57m NOK → 50.45m NOK.
On the constructive side: revenue rose; cash rose; owners injected capital. Pressures included: net result weakened; equity eroded.
Also worth watching: book investments changed. All figures are taken from the published annual accounts for HOFSETH BIOCARE ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 19.29m NOK to 54.78m NOK (+184.0% YoY). Calculated
-
↑
Cash rose
Bank deposits 2.40m NOK → 28.53m NOK (+1088.8% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 98.04m NOK → 110.41m NOK (+12.37m NOK). Reported fact
What deteriorated
-
↓
Net result weakened
Net result -66.92m NOK → -100.20m NOK (net margin -346.9% → -182.9%). Calculated
-
↓
Equity eroded
Book equity 92.57m NOK → 50.45m NOK (equity ratio 43177.2% → 25.5%). Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 5.29m NOK → 12.10m NOK. Reported fact